Otulfi, an ustekinumab biosimilar for the reference product Stelara (ustekinumab), developed by Formycon AG, is now available ...

Key regulatory trends laying the foundation for updated policies, risk-based regulatory frameworks, and forward-looking ...

The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.

Ralston brings more than 25 years of experience providing strategic Market Access and HEOR solutions.

To gain deeper insights into the role of pre-filled syringes in patient-centric packaging, we spoke with Dexter Tjoa, CEO of ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Callio Therapeutics, a biotechnology company, has launched with the closing of a $187.0 million Series A financing round.

AbbVie and Gubra have partnered to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.

Veranova has moved its corporate headquarters to its Devens, Massachusetts site, one of its principal sites for manufacturing and development.

The U.S. Food and Drug Administration (FDA) has approved Fapon Biopharma’s Investigational New Drug (IND) application for ...

Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions.

Chief Science Officer, Peter Surman, shares insight on why pharmaceutical companies should consider softgels for their next ...